Andrea V Margulis

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Endometrial Cancer

Gestational Age

Top Venues

Pharmacoepidemiology and drug safety

Acta ophthalmologica

This page only lists publications with an associated author ORCID identifier.

Publications

Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Stefan de Vogel, John D Seeger, Alejandro Arana, Andrea V Margulis, Lisa J McQuay, Susanna Perez-Gutthann, Nina Sahlertz Kristiansen, Nina Sahlertz Kristiansen, Marie Linder, Ingvild Odsbu, Brandon Suehs, Yihua Xu, Claudia Uribe, Kwame Appenteng, Noah Jamie Robinson
Lessons learned from a multi-data source research collaboration: The mirabegron post-authorization safety study program. Pharmacoepidemiology and drug safety 33 (5) (2024)
Andrea V Margulis, Brian Calingaert, Alison Tse Kawai, Elena Rivero-Ferrer, Mary S Anthony
Distribution of gestational age at birth by maternal and infant characteristics in United States birth certificate data: informing gestational age assumptions when clinical estimates are not available. Pharmacoepidemiology and drug safety (2023)
Djeneba Audrey Djibo, Andrea V Margulis, Cheryl N McMahill-Walraven, Catherine W Saltus, Patricia Shuminski, James A Kaye, Catherine B Johannes, Mark Libertin, Shelli Graham
Validation of an ICD-10 case-finding algorithm for endometrial cancer in US insurance claims. Pharmacoepidemiology and drug safety (2023)
Andrea V Margulis, Krista F Huybrechts
Identification of pregnancies in healthcare data: A changing landscape. Pharmacoepidemiology and drug safety (2022)
Andrea V Margulis, Alison Tse Kawai, Mary S Anthony, Elena Rivero-Ferrer
Perinatal pharmacoepidemiology: How often are key methodological elements reported in publications? Pharmacoepidemiology and drug safety (2021)
Veena Hoffman, Nina Sahlertz Kristiansen, Marie Linder, Andrea V Margulis, Brandon T Suehs, Alejandro Arana, Kelesitse Phiri, Cheryl Enger, Libby Horter, Ingvild Odsbu, Morten Olesen, Susanna Perez-Gutthann, Yihua Xu, Nina Sahlertz Kristiansen, Kwame Appenteng, Stefan de Vogel, John D Seeger, null null
Cardiovascular Risk in Users of Mirabegron Compared with Users of Antimuscarinic Treatments for Overactive Bladder: Findings from a Non-Interventional, Multinational, Cohort Study. Drug safety 44 (8) (2021)
Annete Njue, Carolyn Coyne, Andrea V Margulis, Dai Wang, Morgan A Marks, Kevin Russell, Rituparna Das, Anushua Sinha
The Role of Congenital Cytomegalovirus Infection in Adverse Birth Outcomes: A Review of the Potential Mechanisms. Viruses 13 (1) (2020)
Andrea V Margulis, Sonia Hernandez-Diaz, Thomas McElrath, Kenneth J Rothman, Estel Plana, Catarina Almqvist, Brian M D'Onofrio, Anna Sara Oberg
Relation of in-utero exposure to antiepileptic drugs to pregnancy duration and size at birth. PloS one 14 (8) (2019)
Andrea V Margulis, Marie Linder, Alejandro Arana, Anton Pottegård, Ina Anveden Berglind, Christine L Bui, Nina Sahlertz Kristiansen, Shahram Bahmanyar, Lisa J McQuay, Willem Jan Atsma, Kwame Appenteng, Milbhor D'Silva, Susana Perez-Gutthann, Jesper Hallas
Patterns of use of antimuscarinic drugs to treat overactive bladder in Denmark, Sweden, and the United Kingdom. PloS one 13 (9) (2018)
Andrea V Margulis, Eline Houben, Nina Sahlertz Kristiansen, Jetty A Overbeek, Anton Pottegård, Tobias Torp-Pedersen, Susana Perez-Gutthann, Alejandro Arana
Ophthalmic nepafenac use in the Netherlands and Denmark. Acta ophthalmologica 95 (5) (2017)